We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $18.5M invested in Corvus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more call options, than puts
Call options by funds: $80K | Put options by funds: $60K
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.86% less ownership
Funds ownership: 58.87% → 55.01% (-3.9%)
18% less funds holding
Funds holding: 57 → 47 (-10)
59% less capital invested
Capital invested by funds: $44.9M → $18.5M (-$26.5M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Holders
47
Holders Change
-10
Holders Change %
-17.54%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
13
Reduced
10
Closed
13
Calls
$80K
Puts
$60K
Net Calls
+$20K
Net Calls Change
+$183K
Top Buyers
| 1 |
CA
CHI Advisors
New York
|
+$627K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$245K |
| 3 |
TI
Telemetry Investments
New York
|
+$212K |
| 4 |
Renaissance Technologies
New York
|
+$75.8K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$24.2K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.22M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$837K |
| 3 |
PVI
Pura Vida Investments
New York
|
-$813K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$496K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$229K |
